Rethinking Eye Care: From NanoDropper to Mu Medical
What started as a student project has turned into a company reshaping how eye care is delivered.
In this episode of She Leads Biotech, we’re joined by Allisa Song, CEO of Mu Medical, and Mackenzie Andrews, CCO, to talk about the journey from an idea sparked in a research lab to a product now used across thousands of clinics.
They share how a simple question, why are eye drops too big, led to a solution that improves patient outcomes, reduces waste, and is now evolving into something much bigger.
We also get into co-founder dynamics, building in a complex healthcare system, and the reality of being young female leaders in a traditionally male-dominated space.
A practical, honest conversation about building, scaling, and challenging assumptions in healthcare.
Chapters
00:00 Introduction
01:30 Meet Allisa & Mackenzie
04:00 From Research Lab to Startup Idea
08:30 The Eye Drop Problem Explained
13:00 Building NanoDropper
18:30 When It Became a Real Business
22:00 Product Demo & Clinical Impact
26:00 Go-to-Market Strategy
30:00 Working with Insurers, Clinics & Pharma
34:00 Evolving into Mu Medical
38:00 Co-Founder Dynamics & Trust
42:00 Being Women in a Male-Dominated Industry
47:00 Advice for Founders
51:00 What’s Next for Mu Medical
Listen / Watch:
Spotify | YouTube
#SheLeadsBiotech #MedTech #HealthcareInnovation #WomenInBiotech #CNAUSAExecutiveSearch